VEGFA and Abnormal retinal morphology: Fortunately, the anti-vascular endothelial growth factor (anti-VEGF) medications have revolutionized the treatment of exudative retinal diseases, OCT is critical to guiding the administration of anti-VEGF therapy by providing a clear cross-sectional representation of the retinal pathology in these conditions.